E. Wouters

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.

C. Stove, S. Banister, E. Wouters, 2019, Biochemical pharmacology.

Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L-valine or L-tert-leucine.

C. Stove, V. Auwärter, A. Cannaert, 2019, Drug testing and analysis.

Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.

C. Stove, A. Cannaert, E. Wouters, 2020, Biochemical pharmacology.

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

P. Gallian, P. Simmonds, P. Maes, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy

R. Raedt, C. Stove, D. Van Dam, 2019, PloS one.

Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds.

M. J. Robertson, G. Skiniotis, C. Stove, 2019, ACS pharmacology & translational science.

Assessing GPCR Dimerization in Living Cells: Comparison of the NanoBiT Assay with Related Bioluminescence- and Fluorescence-Based Approaches

F. Ciruela, D. Saini, C. Stove, 2018 .

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary

P. Tiberghien, H. Schrezenmeier, H. Harvala, 2020, Vox sanguinis.